Back to Search

Factor VIII Inhibitor Bypassing Activity (in 200-600 mg human plasma protein) – Uses, Dosage, and Brands in UAE

Brand Name: FEIBA 500 U
Strength: 500 Unit / vial | Form: Powder and solvent for solution for injection
Price in UAE: AED 1959.00
Available in UAE pharmacies

About Factor VIII Inhibitor Bypassing Activity (in 200-600 mg human plasma protein)

Class: | Hemostatic agent, Factor VIII inhibitor bypassing activity Use: | Treatment of bleeding episodes in patients with hemophilia A or B who have developed inhibitors to Factor VIII Adult dose: | 50 to 100 units/kg body weight, administered intravenously; may repeat every 12 to 24 hours as needed, based on clinical response Pediatric dose: | 50 to 100 units/kg body weight, administered intravenously; dosing frequency similar to adults, adjusted based on clinical response Side effects

Drug Class

Hemostatic agent, Factor VIII inhibitor bypassing activity

Uses & Indications

Treatment of bleeding episodes in patients with hemophilia A or B who have developed inhibitors to Factor VIII

Storage Requirements

Store at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light; reconstituted solution should be used immediately or stored at room temperature for no more than 3 hours

Manufacturer & Packaging

Manufacturer: Takeda Manufacturing Austria AG (Vienna - Austria, Austria

Package Size

1 glass Vial powder + 1 Vial with 20ml solvent + 1 baxject II Hi - Flow + 1 kit

Price & Supplier

Price in UAE: AED 1959.00

Dosage Information

Adult Dose

50 to 100 units/kg body weight, administered intravenously; may repeat every 12 to 24 hours as needed, based on clinical response

Pediatric Dose

50 to 100 units/kg body weight, administered intravenously; dosing frequency similar to adults, adjusted based on clinical response

Side Effects

Thromboembolic events, allergic reactions, fever, headache, nausea, and infusion site reactions

Contraindications & Precautions

Known hypersensitivity to any component of the product; active thrombosis or a history of thromboembolic events

Important Warnings

Risk of thrombosis; monitor for signs of thromboembolic events; use with caution in patients with a history of cardiovascular disease or risk factors for thromboembolism

Related Medicines in Same Category

See also: Other Hemostatic agent, Factor VIII inhibitor bypassing activity medicines available in UAE pharmacies

Factor VIII Inhibitor By passing activity (in 20-60 mg human plasma protein)

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. The information presented here is specific to medicines available in UAE pharmacies and is regularly updated to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.

View All Hemostatic agent, Factor VIII inhibitor bypassing activity Medicines Browse All Categories